Filing Details
- Accession Number:
- 0001562180-19-000858
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 17:08:59
- Reporting Period:
- 2019-02-08
- Accepted Time:
- 2019-02-08 17:08:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612859 | Stephen Kanes | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-08 | 22,948 | $150.00 | 941 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The 941 shares reported as beneficially owned were acquired by the reporting person pursuant to the issuer's employee stock purchase plan.
Billionaire Hedge Funds
